Considering the enormous molecular biology efforts to characterize the fate of CD8+ T-cells into very distinct cellular subsets, it is obvious that a simple assessment of CD8 expression, e.g., in the tumor microenvironment, might not be capable of assessing effective immune responses due to the different functionality of the CD8+ T-cell subsets. Here, CD8A is linked to neoplasm.